The major side effects of L ASP were leukocytopenia, elevation of serum bilirubin and hyperglycemia.
本组LASP治疗的不良反应主要表现为白细胞减少、血清胆红素升高和高血糖症。
In the control group, leukocytopenia incidence is 53.3%, vomiting incidence 66.7%, hepatic function lesion incidence 20%, still alopecia and neurologic toxicities occurred.
治疗组没有发生不良反应,对照组白细胞减少发生率为53.3%,恶心呕吐发生率为66.7%,肝功能损害发生率为20%,偶见脱发、神经系统损害等不良反应。
In the control group, leukocytopenia incidence is 53.3%, vomiting incidence 66.7%, hepatic function lesion incidence 20%, still alopecia and neurologic toxicities occurred.
治疗组没有发生不良反应,对照组白细胞减少发生率为53.3%,恶心呕吐发生率为66.7%,肝功能损害发生率为20%,偶见脱发、神经系统损害等不良反应。
应用推荐